Thomas Thum

Thomas Thum

Company: Cardior Pharmaceuticals

Job title: Founder & CSO


Accelerating Non-Coding RNA Therapeutics into Clinical Stages 9:30 am

Moving miRNAs from bench to bedside Next generation heart failure therapeutics Clinical phase 2 design of a miRNA-based programRead more

day: Day Two

Breakfast Panel: What does the Future Landscape of Emerging Non-Coding RNA Therapeutics Look Like?

Ranjan Perera
Director RNA Center & Associate Professor, Johns Hopkins University

9:00 am

What are considered as emerging non-coding RNA therapeutics and where is innovation expected to come from? Outlining the advantages and opportunities that emerging long non-coding RNA therapeutics and microRNAs offer Discussing what the next steps are in the research to accelerate these novel therapeutics into the clinicRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.